User menu

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.

Bibliographic reference Graff, J N ; Baciarello, G ; Armstrong, A J ; Higano, C S ; Iversen, P ; et. al. Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.. In: Annals of Oncology, Vol. 27, no.2, p. 286-294 (2016)
Permanent URL http://hdl.handle.net/2078.1/170870